Clinical Trial Update: Symbiotics and Systemic Inflammation in Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring symbiotics effects on systemic inflammation in chronic kidney disease with Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Systemic Inflammation
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Chronic Renal Failure, Diabete Type 2 | Phase 2 | Status: UNKNOWN